Big Move For Polaryx Therapeutics Inc.
Tue, Feb 17, 2026 at 07:32 PM
Polaryx Therapeutics Inc. (PLYX:NASDAQ) rocketted at $3.96, a gain of 64.3%. The stock appeared on our News Catalysts scanner on Tue, Feb 17, 2026 at 11:45 AM in the 'BIOTECH' category. From Wed, Feb 04, 2026, the stock recorded 12.50% Up Days and 22.22% Green Days
About Polaryx Therapeutics Inc. (PLYX:NASDAQ)
Polaryx Therapeutics is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal...
Top 10 Gainers:
- The OLB Group, Inc. (OLB:NASDAQ), 256.2%
- Signing Day Sports, Inc. (SGN:NYSEMKT), 67.69%
- Polaryx Therapeutics Inc. (PLYX:NASDAQ), 64.32%
- Baird Medical Investment Holdings Limited (BDMD:NASDAQ), 63.64%
- Atomera Incorporated (ATOM:NASDAQ), 46.17%
- Lion Group Holding Ltd. (LGHL:NASDAQ), 45.83%
- Globavend Holdings Limited (GVH:NASDAQ), 41.26%
- LEIFRAS Co. Ltd. (LFS:NASDAQ), 40.19%
- Starfighters Space Inc. (FJET:NYSEMKT), 39.45%
- Gaxos.ai Inc. (GXAI:NASDAQ), 35.24%